טוען...
Infliximab: the evidence for its place in therapy in ulcerative colitis
INTRODUCTION: Refractory ulcerative colitis has a high, unmet medical need for avoiding steroid dependency and avoiding colectomy. Controlled trials with biologic agents have recently been reported. AIMS: We aimed to review the current evidence supporting the use of the monoclonal antitumor necrosis...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2007
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3012439/ https://ncbi.nlm.nih.gov/pubmed/21221182 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|